solo-1: frontline olaparib maintenance therapy in ovarian cancer
Published 4 years ago • 1.1K plays • Length 5:25Download video MP4
Download video MP3
Similar videos
-
6:31
prima: frontline niraparib maintenance therapy in ovarian cancer
-
8:26
the impact of paola-1 on frontline treatment of ovarian cancer
-
26:02
updates in ovarian cancer: frontline maintenance
-
7:09
biomarker-driven frontline ovarian cancer treatment
-
3:13
dr. herzog on the fda approval of olaparib/bevacizumab as frontline maintenance in ovarian cancer
-
1:38
dr. chase on niraparib as frontline maintenance therapy in ovarian cancer
-
3:40
paola-1: combination maintenance therapy in ovarian cancer
-
3:56
solo1 trial of maintenance olaparib in advanced ovarian cancer | susana banerjee
-
7:56
maintenance therapy in ovarian cancer
-
4:54
impact of solo-1 on advanced ovarian cancer management
-
6:03
olaparib maintenance for recurrent ovarian cancer
-
4:40
solo-1 and parp inhibitors in ovarian cancer
-
10:34
solo1: maintenance olaparib in advanced brca ovarian cancer
-
1:57
7-year os from solo1: sustained benefit with maintenance olaparib
-
6:20
parp inhibitors in recurrent ovarian cancer
-
3:42
parp maintenance bevacizumab in ovarian cancer
-
7:24
ovarian cancer: maintenance following frontline bevacizumab
-
2:35
dr. monk on choosing between parp inhibitors in ovarian cancer
-
3:24
solo-1: olaparib or placebo for patients with newly diagnosed brca-mutated advanced ovarian cancer